Cargando…
Synthesis, Biological Activities and Docking Studies of Novel 4-(Arylaminomethyl)benzamide Derivatives as Potential Tyrosine Kinase Inhibitors
A number of new compounds containing the 4-(aminomethyl)benzamide fragment as a linker were designed and synthesized, and their biological activities were evaluated as potential anticancer agents. The cytotoxicity activity of the designed compounds was studied in two hematological and five solid cel...
Autores principales: | Kalinichenko, Elena, Faryna, Aliaksandr, Kondrateva, Viktoria, Vlasova, Alena, Shevchenko, Valentina, Melnik, Alla, Avdoshko, Olga, Belko, Alla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804006/ https://www.ncbi.nlm.nih.gov/pubmed/31574962 http://dx.doi.org/10.3390/molecules24193543 |
Ejemplares similares
-
Novel Phthalic-Based Anticancer Tyrosine Kinase Inhibitors: Design, Synthesis and Biological Activity
por: Kalinichenko, Elena, et al.
Publicado: (2023) -
Synthesis, In Vitro and In Silico Anticancer Activity of New 4-Methylbenzamide Derivatives Containing 2,6-Substituted Purines as Potential Protein Kinases Inhibitors
por: Kalinichenko, Elena, et al.
Publicado: (2021) -
Acid-Catalyzed Condensation of Benzamide with Glyoxal, and Reaction Features
por: Paromov, Artyom, et al.
Publicado: (2022) -
Use of etanercept in management of tyrosine kinase-inhibitor-induced erythema nodosum
por: Alia, Erisa, et al.
Publicado: (2020) -
Tyrosine Kinases in Cancer
por: Blau, Olga, et al.
Publicado: (2015)